C5AR1 and neoplasm: In addition, evidence has shown that the genetic deletion of C3 or C5aR and pharmacological blockade of C5aR impaired the ability of T cells to overcome the endothelial barrier, infiltrate tumors, and control tumor progression in vivo [88].